
Earkart (EARKART) Share Price Falls 9.58% to Rs 117.55; Micro Cap Healthcare Stock Under Pressure
Updated: 7 Oct 2026 • 9:54 am
Posted by:

Earkart Share Price moved lower today, with the stock trading at Rs 117.55 after a 9.58% decline from the previous close of Rs 130. The company’s market capitalisation stood at Rs 178.8 Cr, placing Earkart Share Price in the Micro Cap category. As of 07 October 2026 at 9:53:14 AM IST, the move is relevant because it brings Earkart Share Price into focus for price action, valuation and sector comparison in Healthcare. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers tracking Earkart Share Price Today, the key question is not only the fall, but how the company’s fundamentals and peer ratios frame the move. Univest is also useful here because Earkart Stock News can be read alongside exact valuation and benchmark data.
Earkart (EARKART) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 117.55 |
| Previous Close | Rs 130 |
| Today's Move | -Rs 12.45 (-9.58%) |
| Open | Rs 111 |
| High | Rs 117.55 |
| Low | Rs 111 |
| Market Capitalisation | Rs 178.8 crore |
| Market Cap Category | Micro Cap |
Earkart Share Price today reflected a clear intraday decline, opening at Rs 111, touching a low of Rs 111 and a high of Rs 117.55 before last trading at Rs 117.55. The stock is down Rs 12.45, or 9.58%, versus the previous close of Rs 130. In simple terms, Earkart Share Price traded below its previous session level through the available range and remained at the day’s high by the latest update. The company’s market capitalisation of Rs 178.8 Cr keeps it in the Micro Cap bracket, which is important context for Earkart Share Price Today. No company-specific trigger is established in the verified data, so the move should be read as a confirmed price fall rather than an explained event. For Earkart Stock News readers, the price action itself is the primary fact. That sets up the next layer: Earkart Fundamental Analysis and how valuation stacks up against the industry benchmark.
Earkart (EARKART) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 178.8 crore |
| P/E Ratio | 36.25x |
| P/B Ratio | 2.77x |
| ROE | 40.63% |
| ROCE | 44.39% |
| EPS | Rs 3.59 |
| Book Value Per Share | Rs 46.85 |
| Dividend Yield | 0% |
Earkart (EARKART) fundamental metrics show P/E 36.25x, P/B 2.77x, ROE 40.63%, ROCE 44.39%. These figures provide context only and are not a buy or sell signal.
Earkart has a market capitalisation of Rs 178.80 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 36.25x, P/B at 2.77x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 40.63% and ROCE of 44.39%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.59, book value per share of Rs 46.85, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 34.05x, median ROE of 13.4%, median ROCE of 14.55%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Medical Equipment/Supplies/Accessories |
| Benchmark Scope | same industry |
| Company P/E Ratio | 36.25x |
| Benchmark Median P/E | 34.05x |
| Benchmark Average P/E | 87.95x |
| Benchmark P/E Range | 7.55x to 957.63x |
| Company P/B Ratio | 2.77x |
| Benchmark Median P/B | 3.94x |
| Benchmark Average P/B | 4.27x |
| Company ROE | 40.63% |
| Benchmark Median ROE | 13.4% |
| Benchmark Average ROE | 16.07% |
| Company ROCE | 44.39% |
| Benchmark Median ROCE | 14.55% |
| Benchmark Average ROCE | 17.26% |
| Company Market Capitalisation | Rs 178.8 crore |
| Benchmark Median Market Cap | Rs 173.97 crore |
| Benchmark Average Market Cap | Rs 6,558.18 crore |
Earkart (EARKART) operates in the Healthcare sector, within the Medical Equipment/Supplies/Accessories industry.
Earkart (EARKART) has a P/E ratio of 36.25x, which is above the benchmark median of 34.05x, a difference of +6.46%. On its own, the P/E gap is a valuation reference point, not a trading call.
Earkart (EARKART) has a ROE of 40.63%, which is above the benchmark median of 13.4%, a difference of +203.21%. Earkart (EARKART) has a ROCE of 44.39%, which is above the benchmark median of 14.55%, a difference of +205.09%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| LENSKART SOLUTIONS | LENSKART | 1,20,307.81 | 181.75 | 13.32 | 6.85 | 12.55 |
| Poly Medicure | POLYMED | 16,394.2 | 52.51 | 5.2 | 10.94 | 14.05 |
| Q-LINE BIOTECH | QLINE | 1,547.94 | 27.55 | 6.06 | 25.55 | 22.23 |
| 3B Blackbio Dx | 3BBLACKBIO | 1,399.23 | 24.36 | 4.06 | 20.22 | 25.9 |
| LAXMI DENTAL | LAXMIDENTL | 1,047.76 | 34.05 | 4.28 | 11.95 | 13.29 |
Earkart (EARKART) has a P/E ratio of 36.25x compared with the displayed peer median of 34.05x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 40.63% compares with a peer median of 11.95% across the companies shown in the table. ROCE stood at 44.39% versus the displayed peer median of 14.05%, providing a capital-efficiency comparison. Earkart (EARKART) has a market capitalisation of Rs 178.8 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Earkart
- Earkart Share Price fell 9.58% to Rs 117.55, making today’s move the first point of attention.
- The market capitalisation of Rs 178.8 Cr places Earkart Share Price in the Micro Cap category.
- Earkart Fundamental Analysis shows P/E at 36.25, with P/B at 2.77.
- ROE of 40.63% and ROCE of 44.39% stand above the industry benchmark medians.
- Peer comparison shows Earkart Share Price trading with stronger return ratios than several listed peers.
About Earkart
Earkart operates in Healthcare and is part of the Medical Equipment/Supplies/Accessories industry. The company sits in the same industry benchmark set used here for valuation comparison. On the available profile, Earkart Share Price is tied to a business that belongs to a specialised healthcare segment rather than a broad hospital or pharmacy model. That matters for Earkart Stock News because industry-specific ratios and return metrics often carry more weight than generic market themes. Univest readers following Earkart Share Price Today can therefore view the company through its sector position, market capitalisation and valuation profile rather than only the day’s decline.
Track Earkart Share Price on Univest
Use Earkart (EARKART) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Earkart Share Price on Univest for live updates, valuation ratios, market capitalisation, 52-week levels and the latest market insights. Earkart Share Price Today can also be followed alongside Earkart Stock News, Earkart Stock Analysis and Earkart Fundamental Analysis in one place. For readers watching Earkart Share Price News, Univest provides a simple way to review the price fall and the underlying ratios together.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Earkart Share Price fall today?
Ans. Earkart Share Price fell 9.58% to Rs 117.55 from the previous close of Rs 130. According to Univest data, the price event is confirmed, but no company-specific catalyst is established.
What is Earkart Share Price today?
Ans. Earkart Share Price was last traded at Rs 117.55 as of 07 October 2026 at 9:53:14 AM IST. The stock moved between Rs 111 and Rs 117.55 during the latest range.
What is the market cap of Earkart ?
Ans. Earkart Share Price corresponds to a market capitalisation of Rs 178.8 Cr. That places the company in the Micro Cap category and slightly above the industry benchmark median market cap.
How does Earkart compare with its industry peers?
Ans. Earkart Share Price has a higher P/E than 3B Blackbio Dx and Q-Line Biotech, but lower than Poly Medicure and Lenskart. Its ROE and ROCE are stronger than those listed peers in the comparison set.
What are the key valuation ratios for Earkart Share Price?
Ans. Earkart Share Price carries a P/E of 36.25 and a P/B of 2.77. EPS is Rs 3.59 and book value is Rs 46.85 per share, while dividend yield is 0% in the latest figures.
What do Earkart ROE and ROCE show?
Ans. Earkart Share Price is backed by ROE of 40.63% and ROCE of 44.39. Both figures are above the benchmark medians for the same industry, indicating strong returns on equity and capital employed.
Is Earkart Share Price expensive versus the sector?
Ans. Earkart Share Price has a P/E above the benchmark median of the same industry, but below the benchmark average. Its P/B is below both the median and average, so the valuation picture is mixed.
What does Earkart Fundamental Analysis highlight?
Ans. Earkart Fundamental Analysis highlights a P/E of 36.25, P/B of 2.77, EPS of Rs 3.59 and book value of Rs 46.85. The return ratios are high relative to the industry benchmark.
Where can I track Earkart Share Price News?
Ans. Earkart Share Price News can be tracked on Univest along with live share price, valuation ratios and sector context. That helps place today’s decline alongside the company’s latest financial ratios.
Recent Articles

Top Stocks to Buy for Long Term: Bharti Airtel, Kotak Bank, Eternal Among 9 Stocks Experts Suggest, Check Target Price
13 October 2026

Hong Kong Stock Market: Hang Seng Index Recovers From Intraday Losses, Extends Gains for 3rd Day, What Gave It a Boost?
13 October 2026

Ramkrishna Forgings Share Price Up 34% in 2026: Monarch Networth Sees 18% Upside With Rs 806 Target, Here's Why
13 October 2026

RIL Target Price Ahead of Jio Initial Public Offering: 47% Upside, Why Religare Recommends Buying the Mukesh Ambani Stock Before Issue Launch
13 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Top Stocks to Buy for Long Term: Bharti Airtel, Kotak Bank, Eternal Among 9 Stocks Experts Suggest, Check Target Price
Hong Kong Stock Market: Hang Seng Index Recovers From Intraday Losses, Extends Gains for 3rd Day, What Gave It a Boost?
Ramkrishna Forgings Share Price Up 34% in 2026: Monarch Networth Sees 18% Upside With Rs 806 Target, Here's Why
RIL Target Price Ahead of Jio Initial Public Offering: 47% Upside, Why Religare Recommends Buying the Mukesh Ambani Stock Before Issue Launch
Moneyview Share Price: Newly Listed Stock Gives 83% Returns in 13 Days, Should You Hold for More Gains or Book Profits?
Popular this week
Up 75% in 6 Months, India Glycols Shares Surge 14% Today: Should You Buy? Experts Decode the India Glycols Share Price Rally

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





